Homocysteine reagents for vitex biochemical products
Taiwan·Risk Class 2·ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC·Registered May 04, 2009 – May 04, 2014Cancelled- Analysis ID
- 2e89caaea485cd0bf50d0e2b24e0de38
- Customs Code
- DHA00602000100
- Manufacturer Country
- United States
- Authorized Representative
- Yingshang Zhuangsheng and Zhuangsheng (Hong Kong) Co., Ltd. Taiwan Branch
- Intended Use
- For the quantitative determination of total concentrations of homocysteine (HCY) in human serum and plasma. Homocysteine concentrations in serum and plasma can help diagnose and treat homocysteinemia and homocystinuria.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1377 Cystine-like non-quantitative testing system in urine
- Import Information
- import
- Registration Date
- May 04, 2009
- Expiry Date
- May 04, 2014
- Cancellation Date
- Sep 26, 2016
- Status
- Logged out
- Reason
- 許可證已逾有效期
Access comprehensive regulatory information for Homocysteine reagents for vitex biochemical products in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2e89caaea485cd0bf50d0e2b24e0de38 and manufactured by ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC. The authorized representative in Taiwan is Yingshang Zhuangsheng and Zhuangsheng (Hong Kong) Co., Ltd. Taiwan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.